USPTO serial 79382812
HEY SISTER!
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 19, 2024
- Examiner
- PARKS, KIMBERLY L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HEY SISTER!?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy J. Meagher
Timothy J. Meagher Hamilton, Brook, Smith & Reynolds, P.C.155 Seaport BoulevardBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Articles for feminine hygiene, namely, menstruation pads, tampons and menstruation underwear; female hygiene articles, namely, menstruation pads, tampons and menstruation underwear; feminine hygiene sanitary products, namely, menstruation pads, tampons and menstruation underwear; medicines for human purposes, namely, for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; menstruation pads; menstruation tampons; menstruation underwear; natural healthcare preparations in the nature of medicaments for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; hygiene pads for feminine protection; pain relieving preparations; period underwear, namely, menstrual underwear; khaya senegalensis barks for pharmaceutical purposes for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; decoctions for pharmaceutical purposes, namely, for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; biological preparations for pharmaceutical purposes, namely, for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; hormone preparations for pharmaceutical use; pharmaceutical preparations for the treatment of perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of gynaecological disorders; pharmaceutical preparations for the treatment of premenstrual tension; natural pharmaceutical products for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; pharmaceutical products for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; pharmaceutical products derived from natural sources for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; pharmaceutical substances for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; pharmaceutical preparations in the form of tablets for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; pharmaceutical tablets for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; pharmaceuticals for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; plant extracts for pharmaceutical purposes, namely, for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; plant extracts for pharmaceutical use, namely, for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; premenstrual tension treatment preparations; preparations of plants for pharmaceutical use, namely, for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms; sanitary articles for use in menstrual hygiene, namely, menstruation pads, tampons and menstruation underwear; sanitary pads; sanitary products for feminine hygiene, namely, menstruation pads, tampons and menstruation underwear; sanitary tampons; sanitary undergarments, namely, sanitary underwear; chemical preparations for pharmaceutical purposes, namely, for the treatment of gastrointestinal disorders, gynaelogical disorders, premenstrual tension, perimenopause, menopause, memory loss, sleep disorders, anxiety, fatigue, lung disease, low libido, menstruation pain and associated symptoms | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bioactive Natural Health Pty Ltd
- Other trademarks owned by Bioactive Natural Health Pty Ltd
- Other trademarks owned by Bioactive Natural Health Pty Ltd
- Other trademarks in Class 005
- Similar marks named HEY SISTER!
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 9, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 26, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 21, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 21, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 8, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 8, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 19, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 19, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 19, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 3, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 3, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 14, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 31, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 30, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 30, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 23, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 6, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 6, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 4, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 16, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 15, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 16, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 15, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 9, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |